Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats

Journal of Hepatology

Volumn 24, Issue 6, 1996, Pages 739-746

  Heinemann, Akos ^a   Stauber, Rudolf E ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

5 Hydroxytryptamine; Arginine vasopressin; Desmopressin; Mesenteric arterial bed; Methoxamine; N(G) nitro L arginine methyl ester (L NAME); Nitric oxide; Portal hypertension; Terlipressin

Indexed keywords

ARGIPRESSIN; DESMOPRESSIN; METHOXAMINE; N(G) NITROARGININE METHYL ESTER; SEROTONIN; TERLIPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT;

EID: 0030158211     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80271-6     Document Type: Article

References (36)

1. Finberg JPM, Syrop HA, Better OS. Blunted pressor response to angiotensin and sympathomimetic amines in bile duct-ligated dogs. Clin Sci Mol Med. 61:1981;535-539.
2. Kiel JW, Pitts V, Benoit JN, Granger DN, Shepherd AP. Reduced vascular sensitivity to norepinephrine in portal hypertensive rats. Am J Physiol. 248:1985;G192-G195.
3. Castro A, Jimenez W, Claria J, Ros J, Martinez JM, Bosch M, Arroyo V, Piulats J, Rivera F, Rodes J. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology. 18:1993;367-372.
4. Hartleb M, Moreau R, Cailmail S, Gaudin C, Lebrec D. Vascular hyporesponsiveness to endothelin-1 in rats with cirrhosis. Gastroenterology. 107:1994;1085-1093.
5. Ryan J, Krishnankutty S, Jennings G, Elser M, Dudley F. Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. Gastroenterology. 105:1993;1167-1172.
6. Bomzon A, Blendis LM. Vascular reactivity in experimental portal hypertension. Am J Physiol. 252:1987;G158-G162.
7. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol. 262:1992;G996-G1001.
8. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet. 337:1991;776-778.
9. Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology. 20:1994;1343-1350.
10. Iwata F, Joh T, Kawai T, Itoh M. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol. 263:1992;G149-G154.
11. Garcia-Pagan JC, Fernandez M, Bernadich C, Pizcueta P, Pique JM, Bosch J, Rodes J. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rats. Am J Physiol. 30:1994;G984-G990.
12. Weigert AL, Niederberger M, Gines P, Martin PY, Higa EMS, McMurtry IF, Schrier RW. Endothelium-dependent vascular hyporesponsiveness without nitric oxide synthase induction in aorta of cirrhotic rats. Hepatology. 20:1994;98A.
13. Heinemann A, Stauber RE. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats. Eur J Pharmacol. 278:1995;87-90.
14. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal hypertensive model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol. 244:1983;G52-G57.
15. Blanchet L, Lebrec D. Changes in splanchnic blood flow in portal hypertensive rats. Eur J Clin Invest. 12:1982;327-330.
16. Gimson AES, Westaby D, Hegarty J, Watson A, Williams R. A randomized trial of vasopressin and vasopressin plus nitroglycerin in the treatment of acute variceal hemorrhage. Hepatology. 6:1986;410-413.
17. Walker S, Stiehl A, Raedsch R, Kommerell B. Terlipressin in bleeding esophageal varices: a placebo-controlled doubleblind study. Hepatology. 6:1986;112-115.
18. Westaby D, Gimson A, Hayes PC, Williams R. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension. Gut. 29:1988;372-377.
19. Merkel C, Gatta A, Bolognesi M, Finucci G, Battaglia G, Angeli P, Zuin R. Hemodynamic changes of systemic hepatic and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis. Dig Dis Sci. 33:1988;1103-1109.
20. Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS, Lee SD, Lo KJ. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis. J Hepatol. 10:1990;370-374.
21. Lebrec D, Moreau R, Cailmail S, Sogni P, Oberti F, Hadengue A. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein-stenosed and cirrhotic rats receiving propanolol. J Hepatol. 17:1993;102-107.
22. Karmazyn M, Manku MS, Horrobin DF. Changes of vascular reactivity induced by low vasopressin concentration: interactions with cortisol and lithium and possible involvement of prostaglandin. Endocrinology. 102:1978;1230-1236.
23. Randall MD, Kay AP, Hiley CR. Endothelium-dependent modulation of the pressor activity of arginine vasopressin in the isolated superior mesenteric arterial bed of the rat. Br J Pharmacol. 95:1988;646-652.
24. McGregor DD. The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J Physiol. 177:1965;12-30.
25. +]: a functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J Cardiovasc Pharmacol. 21:1993;423-429.
26. Forsling ML, Aziz LA, Davies R, Donovan B, Miller M. Conversion of triglycylvasopressin to lysine-vasopressin in man. J Endocrinol. 85:1980;237-244.
27. Moreau R, Hadengue A, Soupison T, Mechin G, Assous M, Roche-Sicot J, Sicot C. Abnormal pressor response to vasopressin in patients with cirrhosis: evidence for impaired buffering mechanisms. Hepatology. 12:1990;7-12.
28. Moreau R, Komeichi H, Kirstetter P, Ohsuga M, Cailmail S, Lebrec D. Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis. Gastroenterology. 106:1994;1016-1023.
29. +-channel activities of cultured smooth muscle rcells from porcine coronary artery. Am J Physiol. 263:1992;H491-H496.
30. Huang YT, Lo JW, Lin HC, Tsai YT, Hong CY, Yang MCM. Change in vascular cAMP and cGMP contents in portal hypertensive rats. Pharmacology. 50:1995;86-91.
31. Wu Zy, Shafii A, Benoit JN. Protein kinase-A inhibition restores intestinal microvascular responses to norepinephrine in portal hypertensive rats. Gastroenterology. 106:1994;A280.
32. 2-vascular vasopressin receptors. Regul Pept. 38:1992;1-11.
33. Murray MA, Faraci FM, Heistad DD. Effect of protein kinase C inhibitors on endothelin-and vasopressin-induced constriction of the rat basilary artery. Am J Physiol. 263:1992;H1643-H1649.
34. Eikvar L, Tasken KA, Eskild W, Hansson V. Protein kinase C activation and positive and negative agonist regulation of 3′,5′-cyclic adenosine monophosphate levels in cultured rat Sertoli cells. Acta Endocrinol Copenh. 128:1993;568-572.
35. + channel of cultured porcine coronary artery smooth muscle cells. Biochem Biophys Res Commun. 190:1993;262-269.
36. 2 accumulation in rat IMCD. Am J Physol. 265:1993;F670-F676.